Curcumin Mood Meta-analysis: What the Evidence Says

Quick Answer

Curcumin Mood Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Cognitive impairment, encompassing deficits in memory, attention, executive function, and processing speed, represents one of the most pressing global public health challenges associated with population aging. [Victoria-Montesinos Desirée (2026); evidence level 1]
• Complementing these estimates, data from the Global Burden of Disease (GBD) 2021 study indicate that the prevalence of Alzheimer's disease (AD) and related dementias (ADRD) among adults aged ≥65 years increased by approximately 160% between 1991 and 2021, rising from 18.7 million to 49 million affected individuals globally. [Victoria-Montesinos Desirée (2026); evidence level 1]
• Depression is a leading cause of disability worldwide and is characterised by sustained low mood, anhedonia, anergia, and a range of associated cognitive and somatic symptoms . [Muacevic Alexander (2026); evidence level 4]
• This literature review summarises key randomised controlled trials (RCTs), meta-analyses, safety data, dosing patterns, and guideline positioning for saffron in depressive disorders, with emphasis on adult major depressive disorder (MDD) and related depressive symptomatology. [Muacevic Alexander (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For curcumin mood meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Victoria-Montesinos Desirée (2026). Effects of Zingiberaceae-derived interventions on memory-related and other cognitive outcomes in adults: a systematic review and meta-analysis. DOI: 10.3389/fnut.2026.1834167. PMCID: PMC13198985. PMID: 42199754. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13198985/
• Muacevic Alexander (2026). The Role of Saffron in the Treatment of Depression: A Literature Review. DOI: 10.7759/cureus.104594. PMCID: PMC13044667. PMID: 41939549. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13044667/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.